PortfoliosLab logoPortfoliosLab logo
INSM vs. SAN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

INSM vs. SAN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Insmed Incorporated (INSM) and Banco Santander, S.A. (SAN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, INSM achieves a -45.89% return, which is significantly lower than SAN's 4.95% return. Over the past 10 years, INSM has outperformed SAN with an annualized return of 24.09%, while SAN has yielded a comparatively lower 15.55% annualized return.


INSM

1D
-0.05%
1M
-7.08%
YTD
-45.89%
6M
-52.09%
1Y
27.91%
3Y*
68.17%
5Y*
27.84%
10Y*
24.09%

SAN

1D
0.08%
1M
-0.98%
YTD
4.95%
6M
11.81%
1Y
55.12%
3Y*
58.01%
5Y*
28.22%
10Y*
15.55%
*Multi-year figures are annualized to reflect compound growth (CAGR)

INSM vs. SAN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
INSM
Insmed Incorporated
-45.89%152.09%122.78%55.11%-26.65%-18.17%39.41%82.01%-57.92%135.68%
SAN
Banco Santander, S.A.
4.95%164.72%14.96%46.20%-6.62%10.41%-21.99%-2.32%-28.49%32.28%

Correlation

The correlation between INSM and SAN is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (10Y)
Calculated over the trailing 10-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Jun 2, 2000

0.16

Fundamentals

Market Cap

INSM:

$20.29B

SAN:

$178.48B

EPS

INSM:

-$5.71

SAN:

$1.06

PS Ratio

INSM:

23.84

SAN:

2.48

PB Ratio

INSM:

28.79

SAN:

1.68

Total Revenue (TTM)

INSM:

$819.56M

SAN:

$74.92B

Gross Profit (TTM)

INSM:

$668.55M

SAN:

$46.97B

EBITDA (TTM)

INSM:

-$1.14B

SAN:

$21.14B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INSM vs. SAN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INSM
INSM Risk / Return Rank: 5757
Overall Rank
INSM Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
INSM Sortino Ratio Rank: 5757
Sortino Ratio Rank
INSM Omega Ratio Rank: 6262
Omega Ratio Rank
INSM Calmar Ratio Rank: 5454
Calmar Ratio Rank
INSM Martin Ratio Rank: 5555
Martin Ratio Rank

SAN
SAN Risk / Return Rank: 8282
Overall Rank
SAN Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
SAN Sortino Ratio Rank: 8181
Sortino Ratio Rank
SAN Omega Ratio Rank: 7878
Omega Ratio Rank
SAN Calmar Ratio Rank: 8282
Calmar Ratio Rank
SAN Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INSM vs. SAN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Insmed Incorporated (INSM) and Banco Santander, S.A. (SAN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


INSMSANDifference
Sharpe ratioReturn per unit of total volatility

-1.20

Sortino ratioReturn per unit of downside risk

-1.22

Omega ratioGain probability vs. loss probability

1.17

1.27

-0.11

Calmar ratioReturn relative to maximum drawdown

0.51

2.73

-2.22

Martin ratioReturn relative to average drawdown

1.23

8.45

-7.21

INSM vs. SAN - Sharpe Ratio Comparison

The current INSM Sharpe Ratio is 0.47, which is lower than the SAN Sharpe Ratio of 1.68. The chart below compares the historical Sharpe Ratios of INSM and SAN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


INSMSANDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.47

1.68

-1.20

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.38

0.84

-0.46

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.31

0.44

-0.13

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.02

0.23

-0.25

Drawdowns

INSM vs. SAN - Drawdown Comparison

The maximum INSM drawdown since its inception was -98.65%, which is greater than SAN's maximum drawdown of -82.94%. Use the drawdown chart below to compare losses from any high point for INSM and SAN.


Loading charts...

Drawdown Indicators


INSMSANDifference

Max Drawdown

Largest peak-to-trough decline

-98.65%

-82.94%

-15.71%

Max Drawdown (1Y)

Largest decline over 1 year

-55.46%

-20.29%

-35.17%

Max Drawdown (3Y)

Largest decline over 3 years

-55.46%

-20.29%

-35.17%

Max Drawdown (5Y)

Largest decline over 5 years

-55.46%

-43.63%

-11.83%

Max Drawdown (10Y)

Largest decline over 10 years

-64.84%

-73.84%

+9.00%

Current Drawdown

Current decline from peak

-55.46%

-6.81%

-48.65%

Average Drawdown

Average peak-to-trough decline

-86.11%

-30.67%

-55.44%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.66%

6.55%

+16.11%

Volatility

INSM vs. SAN - Volatility Comparison

Insmed Incorporated (INSM) has a higher volatility of 18.58% compared to Banco Santander, S.A. (SAN) at 8.71%. This indicates that INSM's price experiences larger fluctuations and is considered to be riskier than SAN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


INSMSANDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.58%

8.71%

+9.87%

Volatility (6M)

Calculated over the trailing 6-month period

45.00%

26.85%

+18.15%

Volatility (1Y)

Calculated over the trailing 1-year period

59.24%

33.12%

+26.12%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

72.76%

33.78%

+38.98%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

78.47%

35.87%

+42.60%

Dividends

INSM vs. SAN - Dividend Comparison

INSM has not paid dividends to shareholders, while SAN's dividend yield for the trailing twelve months is around 2.30%.


PositionTTM20252024202320222021202020192018201720162015
INSM
Insmed Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SAN
Banco Santander, S.A.
2.30%2.11%4.63%3.58%3.83%2.71%0.00%6.20%5.83%4.60%3.29%7.06%

Financials

INSM vs. SAN - Financials Comparison

This section allows you to compare key financial metrics between Insmed Incorporated and Banco Santander, S.A.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B25.00B30.00B35.00B20222023202420252026
305.96M
31.44B
(INSM) Total Revenue
(SAN) Total Revenue
Values in USD except per share items

INSM vs. SAN - Profitability Comparison

The chart below illustrates the profitability comparison between Insmed Incorporated and Banco Santander, S.A. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
84.5%
41.2%
Portfolio components
INSM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Insmed Incorporated reported a gross profit of 258.54M and revenue of 305.96M. Therefore, the gross margin over that period was 84.5%.

SAN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Banco Santander, S.A. reported a gross profit of 12.95B and revenue of 31.44B. Therefore, the gross margin over that period was 41.2%.

INSM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Insmed Incorporated reported an operating income of -198.20M and revenue of 305.96M, resulting in an operating margin of -64.8%.

SAN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Banco Santander, S.A. reported an operating income of 5.11B and revenue of 31.44B, resulting in an operating margin of 16.3%.

INSM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Insmed Incorporated reported a net income of -163.56M and revenue of 305.96M, resulting in a net margin of -53.5%.

SAN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Banco Santander, S.A. reported a net income of 5.54B and revenue of 31.44B, resulting in a net margin of 17.6%.


Frequently Asked Questions


INSM and SAN have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INSM has higher volatility (18.58%) compared to SAN (8.71%). In terms of maximum drawdown, INSM dropped -98.65% vs SAN's -82.94%.

SAN currently has the higher Sharpe Ratio (1.68 vs 0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for INSM and SAN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer